+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report 2026-2033- Product Image
Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report 2026-2033- Product Image
New

Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • July 2026
  • Region: Global
  • Grand View Research
  • ID: 4312535
REQUEST CUSTOMIZATION
Description Jump to:
The global pharmaceutical contract manufacturing and research services market size was valued at USD 283.1 billion in 2025 and is projected to grow from USD 303.8 billion in 2026 to USD 472.1 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest share of 42.3% in 2025. The pharmaceutical contract manufacturing and research services industry is anticipated to grow over the forecast period owing to increasing pharmaceutical and biotechnology outsourcing, rising research and development activities for biologics, biosimilars, and specialty drugs, growing demand for cost-efficient and flexible manufacturing, expanding clinical trial pipeline, and increasing investments in advanced manufacturing technologies and integrated CDMO and CRO capabilities.

The market growth is further supported by the need to reduce development timelines, manage complex regulatory requirements, and access specialized technical expertise without large capital investments. The growing focus on end-to-end outsourcing across drug discovery, development, and commercial manufacturing is strengthening demand for contract manufacturing and research service providers.

The increasing outsourcing of pharmaceutical development and manufacturing remains one of the primary growth drivers for the market. Pharmaceutical and biotechnology companies are increasingly partnering with contract service providers to reduce infrastructure costs, improve operational flexibility, and accelerate product development timelines. The growing complexity of biologics, cell and gene therapies, highly potent compounds, and personalized medicines has further increased the need for specialized manufacturing and research capabilities. The integrated service model offered by contract organizations enables sponsors to manage development and commercialization through a single partner while maintaining regulatory compliance and improving operational efficiency.

The expansion of manufacturing capacity and specialized capabilities across leading service providers is further supporting market growth. Companies continue to invest in advanced production technologies and high-value manufacturing infrastructure to address increasing outsourcing demand. For instance, in November 2024, Lonza announced the expansion of its bioconjugation capabilities at its Visp, Switzerland, facility by adding two 1,200 L manufacturing suites to support growing demand for complex therapeutics. The investment is expected to strengthen commercial manufacturing capacity for advanced pharmaceutical products and enhance integrated development and manufacturing services offered to global pharmaceutical and biotechnology companies. Market growth is moderated by stringent regulatory compliance requirements, high capital investment for advanced manufacturing facilities, and pricing pressure across outsourcing contracts. The increasing demand for biologics, specialty therapeutics, integrated development services, and the expansion of pharmaceutical outsourcing across emerging markets are expected to create significant opportunities for contract manufacturing and research service providers over the coming years. Overall, the increasing preference for outsourcing, expanding drug development pipelines, and continuous investments in specialized research and manufacturing capabilities are expected to support the long-term growth of the pharmaceutical contract manufacturing and research services market.

Global Pharmaceutical Contract Manufacturing And Research Services Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global pharmaceutical contract manufacturing and research services market report based on service and region:

Service Outlook (Revenue, USD Million, 2021 - 2033)

  • Manufacturing
  • API/Bulk Drugs
  • Advanced Drug Delivery Formulations
  • Packaging
  • Finished Dose Formulations
  • Solid
  • Liquid
  • Semi-solid Formulations
  • Research
  • Oncology
  • Vaccines
  • Inflammation & Immunology
  • Cardiology
  • Neuroscience
  • Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Contract Manufacturing And Research Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
Chapter 4. Pharmaceutical Contract Manufacturing And Research Services Market: Service Estimates & Trend Analysis
4.1. Pharmaceutical Contract Manufacturing And Research Services Market, Service: Segment Dashboard
4.2. Pharmaceutical Contract Manufacturing And Research Services Market, Service: Movement Analysis
4.3. Pharmaceutical Contract Manufacturing And Research Services Market Estimates & Forecasts, Service, 2021 - 2033 (USD Million)
4.4. Manufacturing
4.4.1. Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. API/Bulk Drugs
4.4.2.1. API/Bulk Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Advanced Drug Delivery Formulations
4.4.3.1. Advanced Drug Delivery Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Packaging
4.4.4.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5. Finished Dose Formulations
4.4.5.1. Finished Dose Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5.2. Solid
4.4.5.2.1. Solid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5.3. Liquid
4.4.5.3.1. Liquid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5.4. Semi-solid Formulations
4.4.5.4.1. Semi-solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Research
4.5.1. Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Oncology
4.5.2.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Vaccines
4.5.3.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Inflammation & Immunology
4.5.4.1. Inflammation & Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Cardiology
4.5.5.1. Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Neuroscience
4.5.6.1. Neuroscience Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.7. Others
4.5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Pharmaceutical Contract Manufacturing And Research Services Market: Regional Estimates & Trend Analysis
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2025 & 2033
5.3. North America
5.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2. U.S
5.3.2.1. Key Country Dynamics
5.3.2.2. Competitive Scenario
5.3.2.3. Regulatory Framework
5.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3. Canada
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Framework
5.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.4. Mexico
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Framework
5.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Europe
5.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. UK
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Framework
5.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3. Germany
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.4. France
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.5. Italy
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Framework
5.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.6. Spain
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Framework
5.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.7. Denmark
5.4.7.1. Key Country Dynamics
5.4.7.2. Competitive Scenario
5.4.7.3. Regulatory Framework
5.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.8. Sweden
5.4.8.1. Key Country Dynamics
5.4.8.2. Competitive Scenario
5.4.8.3. Regulatory Framework
5.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.9. Norway
5.4.9.1. Key Country Dynamics
5.4.9.2. Competitive Scenario
5.4.9.3. Regulatory Framework
5.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Japan
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. China
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.4. India
5.5.4.1. Key Country Dynamics
5.5.4.2. Competitive Scenario
5.5.4.3. Regulatory Framework
5.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.5. Australia
5.5.5.1. Key Country Dynamics
5.5.5.2. Competitive Scenario
5.5.5.3. Regulatory Framework
5.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.6. Thailand
5.5.6.1. Key Country Dynamics
5.5.6.2. Competitive Scenario
5.5.6.3. Regulatory Framework
5.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.7. South Korea
5.5.7.1. Key Country Dynamics
5.5.7.2. Competitive Scenario
5.5.7.3. Regulatory Framework
5.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Latin America
5.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.2. Brazil
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.3. Argentina
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. MEA
5.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.2. South Africa
5.7.2.1. Key Country Dynamics
5.7.2.2. Competitive Scenario
5.7.2.3. Regulatory Framework
5.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.3. UAE
5.7.3.1. Key Country Dynamics
5.7.3.2. Competitive Scenario
5.7.3.3. Regulatory Framework
5.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.4. Saudi Arabia
5.7.4.1. Key Country Dynamics
5.7.4.2. Competitive Scenario
5.7.4.3. Regulatory Framework
5.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.5. Kuwait
5.7.5.1. Key Country Dynamics
5.7.5.2. Competitive Scenario
5.7.5.3. Regulatory Framework
5.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.6. Qatar
5.7.6.1. Key Country Dynamics
5.7.6.2. Competitive Scenario
5.7.6.3. Regulatory Framework
5.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.7. Oman
5.7.7.1. Key Country Dynamics
5.7.7.2. Competitive Scenario
5.7.7.3. Regulatory Framework
5.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Key Participant Categorization
6.1.1. Market Leaders
6.1.2. Emerging Players
6.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
6.3. Company Profiles
6.3.1. Catalent, Inc. (Novo Holdings A/S)
6.3.1.1. Company Overview
6.3.1.2. Financial Performance
6.3.1.3. Service Benchmarking
6.3.1.4. Strategic Initiatives
6.3.2. PPD (Thermo Fisher Scientific Inc.)
6.3.2.1. Company Overview
6.3.2.2. Financial Performance
6.3.2.3. Service Benchmarking
6.3.2.4. Strategic Initiatives
6.3.3. AbbVie Inc.
6.3.3.1. Company Overview
6.3.3.2. Financial Performance
6.3.3.3. Service Benchmarking
6.3.3.4. Strategic Initiatives
6.3.4. Advent International, L.P.
6.3.4.1. Company Overview
6.3.4.2. Financial Performance
6.3.4.3. Service Benchmarking
6.3.4.4. Strategic Initiatives
6.3.5. Grifols
6.3.5.1. Company Overview
6.3.5.2. Financial Performance
6.3.5.3. Service Benchmarking
6.3.5.4. Strategic Initiatives
6.3.6. Dalton Pharma Services
6.3.6.1. Company Overview
6.3.6.2. Financial Performance
6.3.6.3. Service Benchmarking
6.3.6.4. Strategic Initiatives
6.3.7. Lonza
6.3.7.1. Company Overview
6.3.7.2. Financial Performance
6.3.7.3. Service Benchmarking
6.3.7.4. Strategic Initiatives
6.3.8. Boehringer Ingelheim International GmbH
6.3.8.1. Company Overview
6.3.8.2. Financial Performance
6.3.8.3. Service Benchmarking
6.3.8.4. Strategic Initiatives
List of Tables
Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Region, 2021 - 2033 (USD Million)
Table 5 Global Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 6 North America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 7 North America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 8 U.S Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million)
Table 9 Canada Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 10 Mexico Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 11 Europe Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 12 Europe Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 13 UK Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million)
Table 14 Germany Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 15 France Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million)
Table 16 Italy Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 17 Spain Pharmaceutical Contract Manufacturing And Research ServicesMarket Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 18 Denmark Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 19 Sweden Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 20 Norway Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 21 Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 22 Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 23 Japan Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 24 China Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 25 India Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 26 Thailand Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 27 South Korea Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 28 Australia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 29 Latin America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 30 Latin America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 31 Brazil Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 32 Argentina Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 33 Middle East & Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 34 Middle East & Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 35 South Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 36 Saudi Arabia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 37 UAE Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 38 Kuwait Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 39 Oman Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 40 Qatar Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2025 (USD Billion)
Figure 15 Ancillary market outlook, 2025 (USD Billion)
Figure 16 Pharmaceutical Contract Manufacturing And Research Services Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Pharmaceutical Contract Manufacturing And Research Services Market: Service outlook and key takeaways (USD Million)
Figure 20 Pharmaceutical Contract Manufacturing And Research Services Market: Service movement analysis
Figure 21 Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 22 API/Bulk Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 23 Advanced Drug Delivery Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 24 Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 25 Finished Dose Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 26 Solid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 27 Liquid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 28 Semi-solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 29 Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 30 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 31 Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 32 Inflammation & Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 33 Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 34 Neuroscience Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 35 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 36 Regional Marketplace: Key Takeaways
Figure 37 North America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 38 U.S. Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 39 Canada Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 40 Mexico Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 41 Europe Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 42 UK Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 43 Germany Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 44 France Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 45 Italy Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 46 Spain Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 47 Sweden Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 48 Denmark Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 49 Norway Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 50 Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 51 Japan Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 52 China Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 53 India Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 54 Thailand Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 55 South Korea Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 56 Australia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 57 Latin America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 58 Brazil Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 59 Argentina Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 60 Middle East & Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 61 South Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 62 Saudi Arabia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 63 UAE Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 64 Kuwait Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 65 Oman Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 66 Qatar Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Companies Mentioned

  • Catalent, Inc (Novo Holdings A/S)
  • PPD (Thermo Fisher Scientific Inc.)
  • AbbVie Inc.
  • Advent International, L.P.
  • Grifols
  • Dalton Pharma Services
  • Boehringer Ingelheim International GmbH
  • Lonza

Related Topics

Related Reports

Inhaled Drugs Contract Manufacturing Market Forecast to 2033 - Product Image

Inhaled Drugs Contract Manufacturing Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Service, Product, Drug, Scale of Operation, Workflow, Application, End Use, Company, Region, and Growth Forecasts, 2026-2033 - Product Image

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Service, Product, Drug, Scale of Operation, Workflow, Application, End Use, Company, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions - Industry Trends and Forecast 2025-2035 - Product Image

ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions - Industry Trends and Forecast 2025-2035

  • Report
  • 451 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market (5th Edition): Trends and Forecast Till 2035, Geographical Regions and Key Players - Product Image

Pharmaceutical Contract Manufacturing Market (5th Edition): Trends and Forecast Till 2035, Geographical Regions and Key Players

  • Report
  • 545 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market Report 2026-2036 - Product Image

Pharmaceutical Contract Manufacturing Market Report 2026-2036

  • Report
  • 419 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.